LIGAND PHARMACEUTICALS INC short interest in 2021
In 2021, LIGAND PHARMACEUTICALS INC's disclosed short interest ran from 62.20% of shares outstanding on 15 Jan 2021 to 9.66% on 31 Dec 2021, a change of -52.54 percentage points. The year's high was 62.20% on 15 Jan 2021 and its low 9.04% on 31 Mar 2021, averaging 13.69% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 35.08 days on 15 Jan 2021. Full history: LIGAND PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 62.20% (15 Jan 2021)
- End of year
- 9.66% (31 Dec 2021)
- Change
- -52.54 pp
- High
- 62.20% (15 Jan 2021)
- Low
- 9.04% (31 Mar 2021)
- Average
- 13.69%
- Highest days to cover
- 35.08 (15 Jan 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 62.20% | 35.08 | |
| 29 Jan 2021 | 37.10% | 3.90 | |
| 12 Feb 2021 | 17.05% | 3.28 | results (8-K) |
| 26 Feb 2021 | 13.32% | 5.05 | 10-K filed |
| 15 Mar 2021 | 11.22% | 6.59 | |
| 31 Mar 2021 | 9.04% | 6.97 | |
| 15 Apr 2021 | 9.45% | 13.55 | |
| 30 Apr 2021 | 9.72% | 17.77 | |
| 14 May 2021 | 9.58% | 10.28 | results (8-K), 10-Q filed |
| 28 May 2021 | 9.54% | 11.75 | |
| 15 Jun 2021 | 10.33% | 10.84 | |
| 30 Jun 2021 | 10.52% | 8.00 | |
| 15 Jul 2021 | 10.56% | 16.09 | |
| 30 Jul 2021 | 9.89% | 12.78 | results (8-K) |
| 13 Aug 2021 | 9.70% | 13.75 | 10-Q filed |
| 31 Aug 2021 | 9.64% | 6.13 | |
| 15 Sep 2021 | 10.65% | 3.24 | |
| 30 Sep 2021 | 10.40% | 12.58 | |
| 15 Oct 2021 | 9.98% | 17.63 | |
| 29 Oct 2021 | 9.95% | 20.03 | |
| 15 Nov 2021 | 9.50% | 10.05 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.60% | 13.27 | |
| 15 Dec 2021 | 10.07% | 16.82 | |
| 31 Dec 2021 | 9.66% | 10.31 |
See also: LIGAND PHARMACEUTICALS INC's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.